Select Bibliography

Filter by any of these (after searching):

NCCTG-N1048

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 9 items

Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)

Basch, Ethan , Dueck, Amylou C. , Mitchell, Sandra A. , Mamon, Harvey ... - - J Clin Oncol - 2023

Manuscript - Secondary - Primary - Health Outcomes - NCCTG-N1048

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - J Clin Oncol - 2018

Manuscript - Secondary-not-in-original - Primary - Health Outcomes - NCCTG-N1048

Patient-reported adverse events in PROSPECT, a randomized trial of chemotherapy with selective use of pelvic chemoradiation to standard use of chemoradiation for neoadjuvant treatment of locally advanced rectal cancer (Alliance N1048)

Basch, Ethan , Dueck, Amylou , Mitchell, Sandra , Rogak, Lauren ... - ASCO - J Clin Oncol - 2023

Abstract - Secondary - Primary - Health Outcomes - NCCTG-N1048

A cluster-randomized study of clinician-patient shared vs standard reporting of symptomatic adverse events using PRO-CTCAE nested in a multicenter trial of multimodal therapy for rectal cancer (Alliance N1048 PROSPECT)

Dueck, Amylou C. , Mitchell, S.A. , Rogak, Lauren I. , Ginos, Brenda ... - ISOQOL - Qual Life Res - 2015

Abstract - Secondary - Primary - GI - NCCTG-N1048

Variability of Pelvic MRI Performance in a Prospective Multicenter Rectal Cancer Trial NCCTG N1048 (Alliance)

Gollub, Marc J. , Shi, Qian , Nougaret, Stephanie ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary-not-in-original - Primary - GI - NCCTG-N1048

Preoperative Treatment of Locally Advanced Rectal Cancer

Schrag, Deborah , Shi, Qian , Weiser, Martin R. , Gollub, Marc J. ... - - N Engl J Med - 2023

Manuscript - Primary - Primary - GI - NCCTG-N1048

PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by Total Mesorectal Excision (TME) for treatment of locally advanced rectal cancer (LARC). (Alliance N1048)

Schrag, Deborah , Shi, Qian , Weiser, Martin , Gollub, Marc ... - ASCO - JCO - 2023

Abstract - Primary - Primary - GI - NCCTG-N1048

Challenges and Solutions in the Design and Execution of the PROSPECT Phase II/III Neoadjuvant Rectal Cancer Trial (NCCTG N1048/Alliance)

Schrag, Deborah , Weiser, Martin , Saltz, Leonard , Mamon, Harvey ... - - Clin Trials - 2019

Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-N1048

Surgical Quality for Patients treated with Neoadjuvant Chemotherapy versus Chemoradiation for locally advanced rectal cancer (LARC): Results from PROSPECT (Alliance N1048)

Weiser, Martin R. , Shi, Qian , Chang, George J. , Goldberg, Joel ... - ESMO - Ann Oncol - 2023

Abstract - Secondary-not-in-original - Primary - GI - NCCTG-N1048